Litcius/Paper detail

Single-cell RNA transcriptome landscape of hepatocytes and non-parenchymal cells in healthy and NAFLD mouse liver

Qi Su, Sun Y. Kim, Funmi Adewale, Ye Zhou, Christina Aldler, Min Ni, Yi Wei, Michael E. Burczynski, Gurinder S. Atwal, Mark W. Sleeman, Andrew Murphy, Yurong Xin, Xiping Cheng

2021iScience141 citationsDOIOpen Access PDF

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a global health-care problem with limited therapeutic options. To obtain a cellular resolution of pathogenesis, 82,168 single-cell transcriptomes (scRNA-seq) across different NAFLD stages were profiled, identifying hepatocytes and 12 other non-parenchymal cell (NPC) types. scRNA-seq revealed insights into the cellular and molecular mechanisms of the disease. We discovered a dual role for hepatic stellate cells in gene expression regulation and in the potential to trans-differentiate into myofibroblasts. We uncovered distinct expression profiles of Kupffer cells versus monocyte-derived macrophages during NAFLD progression. Kupffer cells showed stronger immune responses, while monocyte-derived macrophages demonstrated a capability for differentiation. Three chimeric NPCs were identified including endothelial-chimeric stellate cells, hepatocyte-chimeric endothelial cells, and endothelial-chimeric Kupffer cells. Our work identified unanticipated aspects of mouse with NAFLD at the single-cell level and advanced the understanding of cellular heterogeneity in NAFLD livers.

Topics & Concepts

Hepatic stellate cellBiologyKupffer cellTranscriptomeHepatocyteCell typeLiver cytologyImmune systemCellNonalcoholic fatty liver diseaseCell biologyMonocyteCancer researchEndothelial stem cellInflammationImmunologyFatty liverGene expressionPathologyGeneMedicineDiseaseEndocrinologyGeneticsIn vitroLiver metabolismLiver Disease Diagnosis and TreatmentLiver physiology and pathologyImmune cells in cancer